GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
GH Research has raised $117.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
GH Research's investors include RA Capital Management, Cormorant Asset Management, Foresite Capital, RTW Investments, Deerfield.
GH Research is headquartered in Dublin, Ireland.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
GH Research is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GH Research — Funding & Investors." VCBacked, April 29, 2026, https://www.vcbacked.co/company/gh-research. Accessed September 2, 2026.
VCBacked. (2026). GH Research — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/gh-research
{{cite web |title=GH Research — Funding & Investors |url=https://www.vcbacked.co/company/gh-research |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated